Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting Therapies.

MLA

Hoffmann, Marie-Christin, et al. “Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies.” Journal of Clinical Immunology, vol. 44, no. 2, Jan. 2024, p. 45. EBSCOhost, https://doi.org/10.1007/s10875-023-01642-0.

APA

Hoffmann, M.-C., Cavalli, G., Fadle, N., Cantoni, E., Regitz, E., Fleser, O., Klemm, P., Zaks, M., Stöger, E., Campochiaro, C., Tomelleri, A., Baldissera, E., Bittenbring, J. T., Zimmer, V., Pfeifer, J., Fischer, Y., Preuss, K.-D., Bewarder, M., Thurner, B., … Thurner, L. (2024). Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies. Journal of Clinical Immunology, 44(2), 45. https://doi.org/10.1007/s10875-023-01642-0

Chicago

Hoffmann, Marie-Christin, Giulio Cavalli, Natalie Fadle, Eleonora Cantoni, Evi Regitz, Octavian Fleser, Philipp Klemm, et al. 2024. “Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies.” Journal of Clinical Immunology 44 (2): 45. doi:10.1007/s10875-023-01642-0.